| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa37665dba7090fae498a7a1c275ff6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fc71568971280f7d43793fa039828f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d0fa02b8e7e088f5a84260c8bd6e29b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2762b97ff59fc48a0007e760b586a0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 |
| filingDate |
2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42064c97ee2c6ec38aa83768e7c9f88a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c357afedbff920e7fba57e21ea2a414e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24c6836b97b113dbd16ac3078e8820d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a9e7ec94c5cf3fe65d674b161f9c75 |
| publicationDate |
2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8389526-B2 |
| titleOfInvention |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| abstract |
The invention relates to compounds of formula (I) and salts thereof n nwherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8507676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9062045-B2 |
| priorityDate |
2009-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |